Global dPCR Market - Drivers and Forecast From Technavio

Technavio has announced the release of their 'global dPCR market 2017-2021' report. (Graphic: Business Wire)

???pagination.previous??? ???pagination.next???

LONDON--()--Technavio analysts forecast the global dPCR market to grow to USD 3.85 billion by 2021, at a CAGR of more than 10% over the forecast period, according to their latest report.

The research study by Technavio on the global digital polymerase chain reaction (dPCR) market for 2017-2021 provides detailed industry analysis based on product (consumables and instruments) and geography (the Americas, EMEA, and APAC).

Digital polymerase chain reaction (dPCR) technology is an advanced version of the PCR technology that enables users to amplify and directly quantify nucleic acids with a high level of precision. The Americas is the dominant regional segment of the dPCR market, generating close to 53% of the overall revenue.

Request a sample report: https://www.technavio.com/request-a-sample?report=57325

Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.

Technavio analysts highlight the following three factors that are contributing to the growth of the global dPCR market:

  • Demand for high throughput technology
  • Rising focus on disease diagnosis, drug discovery, and drug development
  • Rapid technological advances

Demand for high throughput technology

The miniaturization of testing systems has increased the throughput by reducing the number of samples and the time required for obtaining results. The high throughput systems require a lesser amount of sample, which is creating a large demand for these systems,” says Amber Chourasia, a lead analyst at Technavio for lab equipment research.

High throughput dPCR technology not only requires a very little sample, but also provides a high degree of accuracy and productivity in genomic and proteomic research. Therefore, end-users are ready to invest more in high throughput technology to achieve higher efficiency and avoid repetition of testing that leads to wastage of samples.

Rising focus on disease diagnosis, drug discovery, and drug development

Research institutes, pharmaceutical companies, and biotechnology companies are focusing on medical research and drug discovery for several diseases. This is propelling the demand for molecular diagnostic instrumentation solutions such as dPCR instruments and related consumables. For instance, dPCR can reduce the time taken to detect resistance to cancer treatment by up to 15 weeks. Also, the governments of developed and developing countries are supportive of such measures and are encouraging research for new drug discovery and development. With dPCR enabling researchers to achieve breakthroughs in the detection, monitoring, and effective treatment of several diseases and develop new drugs, the demand for the technology is set to increase.

Rapid technological advances

PCR technology has greatly evolved since its inception, with the development of new technologies such as qPCR, RT-PCR, and dPCR. Also, the advanced bioinformatics tools aid researchers in managing a huge amount of data and provide high-quality results from PCR techniques in a short time,” says Amber.

One of the major technologies is the dPCR, which assists researcher by providing highly-sensitive, flexible, and more specific detection of samples compared with traditional PCR. Also, the emergence of ddPCR that uses droplet technology to divide complex samples into smaller sub-units has gained prominence.

Browse Related Reports:

Become a Technavio Insights member and access all three of these reports for a fraction of their original cost. As a Technavio Insights member, you will have immediate access to new reports as they’re published in addition to all 6,000+ existing reports covering segments like furniture and home furnishing; health and wellness; and home, kitchen, and large appliances. This subscription nets you thousands in savings, while staying connected to Technavio’s constant transforming research library, helping you make informed business decisions more efficiently.

About Technavio

Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.

Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, resellers, and end-users.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com

Release Summary

Technavio has announced the release of their global dPCR market 2017-2021 report.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com